Page last updated: 2024-10-31

metoclopramide and Huntington Disease

metoclopramide has been researched along with Huntington Disease in 3 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Research Excerpts

ExcerptRelevanceReference
"Because of vomiting, a 15 years old girl inserted one metoclopramide suppository."3.67[Effect of metoclopramide in a subject at risk for Huntington's chorea]. ( Escousse, A; Fabre, JL; Giroud, M; Nivelon-Chevallier, A; Putelat, R, 1985)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S1
Seeman, P1
Liu, F1
Giroud, M2
Fabre, JL2
Putelat, R2
Caillot, X1
Escousse, A2
Nivelon-Chevalier, A1
Dumas, R1
Nivelon-Chevallier, A1

Other Studies

3 other studies available for metoclopramide and Huntington Disease

ArticleYear
Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia.
    Synapse (New York, N.Y.), 2011, Volume: 65, Issue:2

    Topics: Alzheimer Disease; Animals; Antipsychotic Agents; Dopamine Antagonists; Dose-Response Relationship,

2011
Can metoclopramide reveal Huntington's disease?
    Lancet (London, England), 1982, Nov-20, Volume: 2, Issue:8308

    Topics: Adolescent; Female; Humans; Huntington Disease; Male; Metoclopramide; Pedigree; Suppositories; Vomit

1982
[Effect of metoclopramide in a subject at risk for Huntington's chorea].
    Journal de genetique humaine, 1985, Volume: 33, Issue:2

    Topics: Adolescent; Female; Humans; Huntington Disease; Metoclopramide; Pedigree; Risk; Vomiting

1985